Optima Medical Innovations Corp. (OMIC)
Feb 21, 2025 - OMIC was delisted (reason: acquired by Deerfield)
20.01
0.00 (0.00%)
Inactive · Last trade price on Feb 20, 2025

Redfin Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Sep '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
1.944.615.370.730.390.48
Revenue Growth (YoY)
-72.87%-14.09%633.40%85.81%-18.05%-
Cost of Revenue
1.553.233.660.760.260.44
Gross Profit
0.391.381.71-0.030.140.04
Selling, General & Admin
-0.422.114.184.685.691.14
Research & Development
0.030.10.030.07--
Operating Expenses
0.213.678.657.775.751.18
Operating Income
0.18-2.29-6.94-7.79-5.62-1.14
Interest Expense
-0.19-0.21-0.22-0.01-0.25-0.09
Interest & Investment Income
000.02---
Currency Exchange Gain (Loss)
-0-00---
Other Non Operating Income (Expenses)
-0.03-1.01-0.05--
EBT Excluding Unusual Items
-0.05-3.51-7.14-7.75-5.86-1.23
Merger & Restructuring Charges
----3.38--
Impairment of Goodwill
---5.56---
Gain (Loss) on Sale of Investments
---1.12-0.99--
Gain (Loss) on Sale of Assets
1.681.68----
Asset Writedown
-1.99-1.99-3.82---
Legal Settlements
-0.18-0.18----
Other Unusual Items
0.170.03--3.57--
Pretax Income
-0.37-3.96-17.63-15.7-5.86-1.23
Net Income
-0.37-3.96-17.63-15.7-5.86-1.23
Net Income to Common
-0.37-3.96-17.63-15.7-5.86-1.23
Shares Outstanding (Basic)
5149431462
Shares Outstanding (Diluted)
5149431462
Shares Change (YoY)
7.51%13.12%201.33%136.49%142.58%-
EPS (Basic)
-0.01-0.08-0.41-1.10-0.97-0.49
EPS (Diluted)
-0.01-0.08-0.41-1.10-0.97-0.49
Free Cash Flow
0.21-0.31-2.43-2.09-1.75-0.7
Free Cash Flow Per Share
0.00-0.01-0.06-0.15-0.29-0.28
Gross Margin
20.19%29.93%31.87%-3.80%34.89%7.61%
Operating Margin
9.29%-49.59%-129.19%-1064.40%-1424.87%-237.12%
Profit Margin
-18.81%-85.86%-328.33%-2144.60%-1487.38%-254.89%
Free Cash Flow Margin
10.61%-6.72%-45.24%-284.82%-443.41%-144.77%
EBITDA
0.59-1.73-5.81-7.61-5.55-1.1
EBITDA Margin
30.41%-37.60%-108.28%---229.19%
D&A For EBITDA
0.410.551.120.180.070.04
EBIT
0.18-2.29-6.94-7.79-5.62-1.14
EBIT Margin
9.29%-49.59%-129.19%---237.12%
Revenue as Reported
1.944.615.370.73--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q